WASHINGTON, USA: Manufacturers of generic drugs cannot be sued for adverse side effects caused by products that they did not themselves design, the US Supreme Court ruled on Monday (24 June). 26 Jun 2013
SA's biggest generic drug manufacturer Aspen Pharmacare has offered to buy GlaxoSmithKline's thrombosis drugs and their associated manufacturing site‚ in a potential deal which it says could generate turnover of £300m a year. 19 Jun 2013
WASHINGTON, USA: The Obama administration said this week it would comply with a judge's order to allow women and girls of any age to purchase emergency contraception, ending its efforts to restrict the drug's availability. 12 Jun 2013
WASHINGTON, USA: GlaxoSmithKline's controversial diabetes drug Avandia, restricted in the US and banned in Europe over concerns it raises heart attack risk, is getting a second look this week by US medical experts. 6 Jun 2013
How our bodies break down the common drugs ibuprofen, diclofenac and warfarin is the subject of a new study from the University of Bristol, published in the Journal of the American Chemical Society. The research should ultimately help predict how new drugs will be metabolized in the body, potentially helping avoid adverse drug reactions in future. 28 May 2013
WASHINGTON, USA: American authorities said on Monday (13 May) that a US$500m fine would be imposed on Indian generic pharmaceutical manufacturer Ranbaxy after it pleaded guilty to selling adulterated drugs in the United States. 15 May 2013
The Australian medicines regulator has been forced to let generic drug giant Aspen Pharmacare continue selling painkillers containing the controversial ingredient dextropropoxyphene (DPP)‚ a development that local rival Adcock Ingram says could strengthen its bid to get its once highly lucrative versions back on the market in SA. 11 Apr 2013
Some medications can cause a loss of hearing, offering an ototoxic risk. A prime example is the risk associated with TB medication. 26 Mar 2013
Bidvest's offer for 60% of Adcock Ingram's shares is in line with its strategy of buying under-performing assets at their lowest ebb‚ according to analysts. 25 Mar 2013
SA's biggest drug manufacturer Aspen Pharmacare expects its Asia-Pacific business to generate the biggest share of the company's revenue by the end of the year‚ its chief executive Stephen Saad said at the release of its interim results for the six months to December. 8 Mar 2013
With over 100 000 non-prescription or over-the-counter (OTC) medicines and self-care knowledge readily available, cash-strapped South Africans needn't compromise their health simply because they cannot afford a doctor consultation or prescription medicine. 29 Jan 2013
Pharmaceutical companies will be allowed to hike their private sector prices by a maximum of 5.8% this year‚ the Department of Health announced on Tuesday (22 January) - a move that is likely to disappoint the local manufacturing industry. 24 Jan 2013
Adcock Ingram on Friday, 18 January 2013, announced the completion of the acquisition of Cosme Farma Laboratories Limited, a pan-Indian pharmaceutical company based in Goa, India for R745 million. 21 Jan 2013
Sub-Saharan Africa offers significant opportunities for SA's pharmaceutical manufacturing companies‚ as a growing middle class and an increasing disease burden push up demand for medicines‚ according to research by Frost & Sullivan. 17 Jan 2013
With the R1,4bn contract to supply the state with antiretroviral (ARV) drugs, Cipla Medpro SA has found a remedy for its struggling manufacturing division - at least for the next two years. 16 Dec 2012
South Africa's third biggest pharmaceutical company Cipla Medpro announced on Monday (26 November) that its chief financial officer Chris Aucamp had resigned with immediate effect‚ but would remain a director of one of its subsidiaries Medpro Pharmaceutical until at least the end of March. 27 Nov 2012
The Centre for Drug Evaluation and Research of the Food and Drug Administration (FDA) has accepted Adcock Ingram's Research and Development (R&D) facility, which is located in Aeroton, south of Johannesburg. Adcock Ingram's R&D facility is registered with the Medicines Control Council (MCC) as a current Good Manufacturing Practice facility. 2 Nov 2012
Aspen has launched Enze-Lact capsules and drops, aimed at those who have difficulty digesting lactose containing milk or food products. The symptoms of lactose intolerance include diarrhoea, bloating, flatulence and abdominal pain. 25 Oct 2012
Cipla Medpro's (CMP) suspended CEO‚ Jerome Smith‚ has resigned on the eve of a disciplinary hearing against him‚ a move that analysts say may pave the way for a takeover of the local pharmaceutical company‚ Business Day reported on Monday, 8 October 2012. 8 Oct 2012
Cipla Medpro (CMP) on Monday announced in a note that its suspended CEO‚ Jerome Smith‚ is facing more than 20 charges ranging from gross misconduct to gross dishonesty. 8 Oct 2012
Let's do Biz